2178-P: Effects of Lowering Carbohydrate Amount and Glycemic Index on Whole-Body and Organ-Specific Aging Proteins and Postprandial Glucose Metabolism: The OmniCarb Trial
Diabetes · 05.06.2026 · 75 (Supplement_1)
DOI: 10.2337/db26-2178-p ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, erschienen am 05.06.2026. Verfasst von YORIKO HEIANZA und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction and Objective: Carbohydrate digestion and glucose tolerance decline with age. Proteomics has emerged as a powerful tool for assessing biological aging. We investigated whether reducing carbohydrate (carb) intake and dietary glycemic index (GI) altered aging-related proteins and their associations with postprandial glucose metabolism.
Methods
The study included participants from the OmniCarb crossover feeding trial, who consumed a high-carb, high-GI diet and a low-carb, low-GI diet for 5 weeks each. Participants completed 12-hour meal tests (n = 48); the area under the curve of glucose (AUC-glu) was calculated. We analyzed 231 validated aging-related proteins measured by Olink proteomics.
Results
Lowering carb amount and GI modified several liver- and brain-aging proteins (PFDR <0.05), including fibroblast growth factor 21 (FGF21), oxytocin (OXT), and carnosine dipeptidase 1 (CNDP1). Whole-body aging proteins and epidermal growth factor receptor (EGFR) were also altered (Figure). Diet-responsive proteins were associated with differences in AUC-glu (β 2690 [SE 1108]; P = 0.019 per 1 SD increase of FGF21 on a high-carb and high-GI diet). Between-diet changes in CNDP1 and EGFR were also related to changes in AUC-glu (P < 0.05).
Conclusion
Reducing carb and GI levels modified proteomic pathways related to biological aging and were linked to regulation of half-day postprandial hyperglycemia. Disclosure Y. Heianza: None. Q. Sun: None. F. Hu: None. L.J. Appel: Other - Payment for chapters in UpToDate on the relationship of hypertension with sodium, weight, exercise and smoking; Current; Wolters Kluwer. F.M. Sacks: None. L. Qi: None. Funding American Diabetes Association (7-25-ICTSAD-0480), National Institutes of Health (DK091718, DK100383, DK115679, 2P20GM109036-06A1)
Zitieren
APA
HEIANZA, Y., SUN, Q., HU, F., APPEL, L. J., SACKS, F. M., & QI, L. (2026). 2178-P: Effects of Lowering Carbohydrate Amount and Glycemic Index on Whole-Body and Organ-Specific Aging Proteins and Postprandial Glucose Metabolism: The OmniCarb Trial. Diabetes, 75(Supplement_1). https://doi.org/10.2337/db26-2178-p
Vancouver
HEIANZA Y, SUN Q, HU F, APPEL LJ, SACKS FM, QI L. 2178-P: Effects of Lowering Carbohydrate Amount and Glycemic Index on Whole-Body and Organ-Specific Aging Proteins and Postprandial Glucose Metabolism: The OmniCarb Trial. Diabetes. 2026;75(Supplement_1). doi:10.2337/db26-2178-p
BibTeX
@article{HEIANZA2026,
author = {HEIANZA, YORIKO and SUN, QI and HU, FRANK and APPEL, LAWRENCE J. and SACKS, FRANK M. and QI, LU},
title = {2178-P: Effects of Lowering Carbohydrate Amount and Glycemic Index on Whole-Body and Organ-Specific Aging Proteins and Postprandial Glucose Metabolism: The OmniCarb Trial},
journal = {Diabetes},
year = {2026},
volume = {75},
number = {Supplement_1},
doi = {10.2337/db26-2178-p}
}
EUVIMED